Regional Intelligence Command Center
Real-time denial patterns, payer intelligence, and contract negotiation data across US markets
National Avg Denial Rate
21.6%
Across all payers & categories
Avg Appeal Overturn
28.0%
Successful reversals on appeal
Highest Denial State
MA
28.7% denial rate
Most Favorable State
NC
13.5% denial rate
Market Overview — State-Level Denial Rates
| State | Region | Denial Rate | Trend | Overturn Rate | Avg Resolution Days | Top Denial Reason |
|---|---|---|---|---|---|---|
| CA | West | 22.9% | 8.3% | 36% | 36 days | Lack of Clinical Justification |
| TX | South | 22% | 8.1% | 28.3% | 35 days | Insufficient Medical Documentation |
| FL | South | 13.8% | 8.8% | 34% | 57 days | Lack of Clinical Justification |
| NY | Northeast | 16.1% | 5.6% | 25.8% | 40 days | Out of Network Provider |
| PA | Northeast | 26.1% | 10.9% | 23.5% | 50 days | Failed Prior Authorization |
| IL | Midwest | 26.8% | 2.7% | 25% | 32 days | Failed Prior Authorization |
| OH | Midwest | 20.2% | 3.1% | 31.8% | 36 days | Insufficient Medical Documentation |
| GA | South | 24.5% | 9.3% | 31.2% | 50 days | Failed Prior Authorization |
| NC | South | 13.5% | 3.1% | 17.9% | 48 days | Lack of Clinical Justification |
| MI | Midwest | 22.8% | 10.4% | 38.4% | 37 days | Experimental Treatment |
| NJ | Northeast | 24.8% | 2.9% | 19% | 51 days | Lack of Clinical Justification |
| VA | South | 20.6% | 3.1% | 38.6% | 45 days | Out of Network Provider |
| WA | West | 24% | 1.3% | 23.3% | 39 days | Failed Prior Authorization |
| AZ | West | 17.4% | 0.9% | 17.7% | 48 days | Lack of Clinical Justification |
| MA | Northeast | 28.7% | 7.4% | 28.9% | 31 days | Coding Error / Bundling Issue |
Payer Comparison Matrix — Denial Rates by CPT Category
| Payer | Imaging Denial Rate | Market Share | 6M Trend | Total Claims | Comparative Position |
|---|---|---|---|---|---|
| UnitedHealthcare | 11.6% | 5.5% | ↑ 11.9% | 9,944 | More lenient than avg |
| Anthem BCBS | 21.9% | 9.9% | ↑ 8.6% | 7,159 | Stricter than avg |
| Aetna | 22.6% | 18.8% | ↓ 5.1% | 7,163 | Stricter than avg |
| Cigna | 26.1% | 13.8% | ↑ 0.2% | 11,596 | Stricter than avg |
| Humana | 20.3% | 12.6% | ↑ 1.5% | 13,395 | More lenient than avg |
| Blue Cross | 24.5% | 16.5% | ↑ 12.8% | 5,561 | Stricter than avg |
| State Medicaid | 20.6% | 10.9% | ↓ 5.6% | 12,986 | More lenient than avg |
| Medicare (CMS) | 22.8% | 12.1% | ↑ 9.6% | 9,475 | Stricter than avg |
Plan-Level Intelligence
Drill into specific health plans for detailed denial metrics and appeal strategies
UnitedHealthcare Plan 1
UnitedHealthcare
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
UnitedHealthcare Plan 2
UnitedHealthcare
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Anthem BCBS Plan 1
Anthem BCBS
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Anthem BCBS Plan 2
Anthem BCBS
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Aetna Plan 1
Aetna
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Aetna Plan 2
Aetna
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Regional Policy Changes & Trending Alerts
UnitedHealthcare Imaging Denial Surge
Imaging denials increased 8.3% YoY. New prior auth requirements effective March 2026.
Anthem Step Therapy Expansion
Anthem expanding step therapy to infusion/biologics. Biologic approvals require 8-week conventional trial.
Medicaid Approval Trend Positive
State Medicaid programs showing 3.2% improvement in appeal overturn rates.
Contract Negotiation Ammunition
Data-backed negotiation talking points by payer
UnitedHealthcare — Imaging Overreach
- • Imaging denial rate: 24.3% (national avg: 21.6%)
- • YoY increase: +8.3% — highest among major competitors
- • Appeal overturn rate: 18.2% suggests denials not clinically justified
- • Benchmark: Aetna imaging denials at 16.7%, demonstrating more rational approach
Anthem — Overly Aggressive Step Therapy
- • Infusion/biologic denial rate: 28.5% (payer avg: 18.3%)
- • New 8-week conventional therapy requirement adds 40+ days to approval
- • Blue Cross plan competing on your network approves at 14.2% denial rate
- • Consider network reduction penalty clause in RFP response
Regional Opportunity — Texas/FL Markets
- • Texas denial rate: 14.2% (lowest in South region)
- • Florida Medicaid: 22.8% denial rate but 32% appeal overturn
- • Negotiation lever: "Your denial rates trailing regional peers by 6.1%"
- • Opportunity: Volume rebates if deny rate improves to regional median
Benchmark Comparison — Appeal Economics
- • National appeal success rate: 28.0%
- • High-denial payers (>20%) showing appeal success of 25%+
- • Cost to hospitals: $500-1,000 per appeal dispute
- • Propose: Monthly denial reconciliation calls to reduce appeals by 30%
Network Performance Benchmarks
How your hospital network compares to regional peers
Your Network (Simulated)
16.2%
Overall denial rate
Regional Peer Average
18.4%
200-300 bed hospitals, same region
Best-in-Class Benchmark
11.8%
Top 10% of networks nationally
Position: Your denial rate is 2.2 percentage points better than regional peers. With targeted clinical documentation improvements, best-in-class position is achievable within 6 months. This translates to ~$280K in recovered revenue annually based on current claim volume.